Ansell Limited (ANSLY)
USD 83.43
(0.0%)
USD 83.43
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 129.3 Million USD | -34.32% |
| 2023 | 196.86 Million USD | -15.73% |
| 2022 | 233.61 Million USD | -32.05% |
| 2021 | 343.81 Million USD | 54.5% |
| 2020 | 222.53 Million USD | 15.16% |
| 2019 | 193.24 Million USD | 2.02% |
| 2018 | 189.42 Million USD | 4.79% |
| 2017 | 180.77 Million USD | -10.68% |
| 2016 | 202.38 Million USD | 9.39% |
| 2015 | 185.01 Million USD | 31.47% |
| 2014 | 140.73 Million USD | 19.76% |
| 2013 | 117.5 Million USD | -10.99% |
| 2012 | 132.01 Million USD | -1.79% |
| 2011 | 134.42 Million USD | 59.32% |
| 2010 | 84.37 Million USD | 18.99% |
| 2009 | 70.9 Million USD | -13.94% |
| 2008 | 82.39 Million USD | 19.52% |
| 2007 | 68.93 Million USD | -32.32% |
| 2006 | 101.85 Million USD | 43.41% |
| 2005 | 71.02 Million USD | 25.86% |
| 2004 | 56.42 Million USD | 27.96% |
| 2003 | 44.1 Million USD | 130.88% |
| 2002 | 19.1 Million USD | 152.09% |
| 2001 | -36.67 Million USD | -209.1% |
| 2000 | 33.61 Million USD | -75.22% |
| 1999 | 135.65 Million USD | 59.56% |
| 1998 | 85.02 Million USD | -98.16% |
| 1997 | 4.6 Billion USD | -5.5% |
| 1996 | 4.87 Billion USD | -2.27% |
| 1995 | 4.99 Billion USD | 2.69% |
| 1994 | 4.86 Billion USD | 19.51% |
| 1993 | 4.06 Billion USD | -2.56% |
| 1992 | 4.17 Billion USD | 14.18% |
| 1991 | 3.65 Billion USD | -5.89% |
| 1990 | 3.88 Billion USD | 16.56% |
| 1989 | 3.33 Billion USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | 195.2 Million USD | -0.85% |
| 2024 Q4 | 89.4 Million USD | 99.13% |
| 2024 Q3 | 44.9 Million USD | 13.67% |
| 2024 Q2 | 39.5 Million USD | 1.02% |
| 2024 Q1 | 39.1 Million USD | -66.58% |
| 2023 FY | 196.86 Million USD | -15.73% |
| 2023 Q1 | 46.5 Million USD | -62.5% |
| 2023 Q2 | 93 Million USD | 100.0% |
| 2023 Q3 | 58.75 Million USD | -36.83% |
| 2023 Q4 | 116.99 Million USD | 99.14% |
| 2022 FY | 233.61 Million USD | -32.05% |
| 2022 Q4 | 124 Million USD | 0.0% |
| 2022 Q2 | 113.7 Million USD | 0.0% |
| 2021 Q4 | 179.08 Million USD | 0.0% |
| 2021 FY | 343.81 Million USD | 54.5% |
| 2021 Q2 | 144.7 Million USD | 0.0% |
| 2020 Q2 | 91.8 Million USD | 0.0% |
| 2020 Q4 | 130.6 Million USD | 0.0% |
| 2020 FY | 222.53 Million USD | 15.16% |
| 2019 Q4 | 115.34 Million USD | 0.0% |
| 2019 FY | 193.24 Million USD | 2.02% |
| 2019 Q2 | 124.36 Million USD | 0.0% |
| 2018 Q2 | 93.67 Million USD | 0.0% |
| 2018 FY | 189.42 Million USD | 4.79% |
| 2018 Q4 | 162.13 Million USD | 0.0% |
| 2017 Q2 | 113.35 Million USD | 0.0% |
| 2017 FY | 180.77 Million USD | -10.68% |
| 2017 Q4 | 124.9 Million USD | 0.0% |
| 2016 Q2 | 136.35 Million USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 FY | 202.38 Million USD | 9.39% |
| 2015 Q4 | 184.89 Million USD | 0.0% |
| 2015 Q2 | 144.56 Million USD | 0.0% |
| 2015 FY | 185.01 Million USD | 31.47% |
| 2014 Q1 | 39.09 Million USD | -63.44% |
| 2014 Q2 | 92.47 Million USD | 136.53% |
| 2014 Q3 | 45.35 Million USD | -50.96% |
| 2014 FY | 140.73 Million USD | 19.76% |
| 2014 Q4 | 131.27 Million USD | 189.45% |
| 2013 Q4 | 106.94 Million USD | 145.22% |
| 2013 FY | 117.5 Million USD | -10.99% |
| 2013 Q1 | 38.83 Million USD | 0.0% |
| 2013 Q2 | 43.6 Million USD | 12.29% |
| 2013 Q3 | 43.61 Million USD | 0.02% |
| 2012 Q2 | 39.97 Million USD | 18.28% |
| 2012 Q4 | - USD | -100.0% |
| 2012 FY | 132.01 Million USD | -1.79% |
| 2012 Q1 | 33.8 Million USD | 0.0% |
| 2012 Q3 | 38.82 Million USD | -2.9% |
| 2011 Q1 | 34.64 Million USD | 0.0% |
| 2011 FY | 134.42 Million USD | 59.32% |
| 2011 Q4 | - USD | -100.0% |
| 2011 Q3 | 35.87 Million USD | 3.95% |
| 2011 Q2 | 34.51 Million USD | -0.37% |
| 2010 FY | 84.37 Million USD | 18.99% |
| 2010 Q4 | - USD | -100.0% |
| 2010 Q3 | 32.89 Million USD | 3.18% |
| 2010 Q1 | 31.02 Million USD | 0.0% |
| 2010 Q2 | 31.87 Million USD | 2.74% |
| 2009 Q4 | - USD | -100.0% |
| 2009 FY | 70.9 Million USD | -13.94% |
| 2009 Q1 | 23.79 Million USD | 0.0% |
| 2009 Q2 | 23.04 Million USD | -3.17% |
| 2009 Q3 | 25.21 Million USD | 9.4% |
| 2008 FY | 82.39 Million USD | 19.52% |
| 2008 Q3 | 28.32 Million USD | 2.02% |
| 2008 Q2 | 27.76 Million USD | 2.59% |
| 2008 Q1 | 27.05 Million USD | 0.0% |
| 2008 Q4 | - USD | -100.0% |
| 2007 Q1 | 25.82 Million USD | 0.0% |
| 2007 Q4 | - USD | -100.0% |
| 2007 Q3 | 24.8 Million USD | 4.45% |
| 2007 Q2 | 23.74 Million USD | -8.06% |
| 2007 FY | 68.93 Million USD | -32.32% |
| 2006 FY | 101.85 Million USD | 43.41% |
| 2006 Q1 | 23.36 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q2 | 25.9 Million USD | 10.85% |
| 2006 Q3 | 24.54 Million USD | -5.26% |
| 2005 Q1 | 20.7 Million USD | 0.0% |
| 2005 FY | 71.02 Million USD | 25.86% |
| 2005 Q2 | 23.78 Million USD | 14.89% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 23.69 Million USD | -0.39% |
| 2004 FY | 56.42 Million USD | 27.96% |
| 2004 Q2 | 21.98 Million USD | 33.59% |
| 2004 Q1 | 16.45 Million USD | 0.0% |
| 2004 Q4 | - USD | -100.0% |
| 2004 Q3 | 21.77 Million USD | -0.93% |
| 2003 FY | 44.1 Million USD | 130.88% |
| 2003 Q2 | 14.16 Million USD | -26.88% |
| 2003 Q1 | 19.36 Million USD | 0.0% |
| 2003 Q4 | - USD | -100.0% |
| 2003 Q3 | 14.46 Million USD | 2.16% |
| 2002 Q4 | - USD | -100.0% |
| 2002 Q3 | 18.9 Million USD | 4.45% |
| 2002 FY | 19.1 Million USD | 152.09% |
| 2002 Q1 | 493.58 Million USD | 0.0% |
| 2002 Q2 | 18.1 Million USD | -96.33% |
| 2001 Q1 | 12.26 Million USD | 0.0% |
| 2001 FY | -36.67 Million USD | -209.1% |
| 2001 Q4 | - USD | -100.0% |
| 2001 Q3 | 491.63 Million USD | -10.97% |
| 2001 Q2 | 552.23 Million USD | 4403.82% |
| 2000 FY | 33.61 Million USD | -75.22% |
| 2000 Q1 | 49.16 Million USD | 0.0% |
| 2000 Q3 | 13.7 Million USD | -5.61% |
| 2000 Q2 | 14.51 Million USD | -70.47% |
| 2000 Q4 | - USD | -100.0% |
| 1999 Q4 | - USD | -100.0% |
| 1999 FY | 135.65 Million USD | 59.56% |
| 1999 Q3 | 47.38 Million USD | 0.27% |
| 1999 Q1 | 33.13 Million USD | 0.0% |
| 1999 Q2 | 47.25 Million USD | 42.61% |
| 1998 Q4 | - USD | -100.0% |
| 1998 FY | 85.02 Million USD | -98.16% |
| 1998 Q3 | 36.66 Million USD | -3.21% |
| 1998 Q1 | 1.11 Billion USD | 0.0% |
| 1998 Q2 | 37.88 Million USD | -96.61% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q3 | 1.2 Billion USD | 2.31% |
| 1997 Q1 | 1.22 Billion USD | 0.2% |
| 1997 FY | 4.6 Billion USD | -5.5% |
| 1997 Q2 | 1.17 Billion USD | -3.55% |
| 1996 Q1 | 1.31 Billion USD | 5.73% |
| 1996 FY | 4.87 Billion USD | -2.27% |
| 1996 Q2 | 1.15 Billion USD | -12.08% |
| 1996 Q3 | 1.2 Billion USD | 4.06% |
| 1996 Q4 | 1.21 Billion USD | 1.03% |
| 1995 Q3 | 1.27 Billion USD | -3.37% |
| 1995 Q4 | 1.24 Billion USD | -2.34% |
| 1995 FY | 4.99 Billion USD | 2.69% |
| 1995 Q1 | 1.23 Billion USD | 1.58% |
| 1995 Q2 | 1.32 Billion USD | 7.12% |
| 1994 Q1 | 980.52 Million USD | -3.57% |
| 1994 FY | 4.86 Billion USD | 19.51% |
| 1994 Q4 | 1.21 Billion USD | 3.49% |
| 1994 Q2 | 1.18 Billion USD | 20.72% |
| 1994 Q3 | 1.17 Billion USD | -0.8% |
| 1993 Q3 | 1.06 Billion USD | 3.72% |
| 1993 Q4 | 1.01 Billion USD | -4.5% |
| 1993 FY | 4.06 Billion USD | -2.56% |
| 1993 Q2 | 1.02 Billion USD | 2.33% |
| 1993 Q1 | 1 Billion USD | -3.88% |
| 1992 Q4 | 1.04 Billion USD | -2.8% |
| 1992 FY | 4.17 Billion USD | 14.18% |
| 1992 Q1 | 949.81 Million USD | 3.93% |
| 1992 Q2 | 1.04 Billion USD | 10.29% |
| 1992 Q3 | 1.07 Billion USD | 2.49% |
| 1991 Q3 | 923.05 Million USD | -1.11% |
| 1991 Q4 | 913.93 Million USD | -0.99% |
| 1991 Q2 | 933.41 Million USD | -8.35% |
| 1991 FY | 3.65 Billion USD | -5.89% |
| 1991 Q1 | 1.01 Billion USD | 4.87% |
| 1990 Q1 | 854.02 Million USD | 2.5% |
| 1990 Q2 | 947.03 Million USD | 10.89% |
| 1990 Q3 | 924.88 Million USD | -2.34% |
| 1990 Q4 | 971.14 Million USD | 5.0% |
| 1990 FY | 3.88 Billion USD | 16.56% |
| 1989 Q2 | 970.88 Million USD | 0.0% |
| 1989 FY | 3.33 Billion USD | 0.0% |
| 1989 Q4 | 833.19 Million USD | -7.21% |
| 1989 Q3 | 897.95 Million USD | -7.51% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -11006.148% |
| Ansell Limited | 129.3 Million USD | 0.0% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -315.246% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 8203.022% |
| Psykey, Inc. | -797.5 Thousand USD | 16313.085% |
| ConvaTec Group Plc | 262.7 Million USD | 50.78% |
| ConvaTec Group Plc | 262.7 Million USD | 50.78% |
| Encision Inc. | -640.78 Thousand USD | 20278.438% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 91278.337% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 117720.304% |
| Innovative MedTech Inc. | -4.27 Million USD | 3125.215% |
| LifePoint, Inc. | -7.49 Million USD | 1825.098% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 2095.37% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -39081.818% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 105316.047% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 27770.894% |
| SmileDirectClub, Inc. | -241.15 Million USD | 153.617% |
| Sector 10, Inc. | -39.84 Thousand USD | 324615.611% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 59.544% |
| SheerVision, Inc. | 155.72 Thousand USD | -82930.451% |
| United Health Products, Inc. | -2.42 Million USD | 5428.577% |
| Vasamed, Inc. | 4.74 Million USD | -2626.524% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 5736.096% |
| Yubo International Biotech Limited | -1.2 Million USD | 10828.305% |